Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Sophiris Bio, Inc. (NASDAQ: SPHS).

Full DD Report for SPHS

You must become a subscriber to view this report.


Recent News from (NASDAQ: SPHS)

Today's Research Reports on Stocks to Watch: Opiant Pharmaceuticals and Sophiris Bio
NEW YORK, NY / ACCESSWIRE / August 30, 2018 / Shares of Opiant saw big gains after Wall Street learned that Emergent Biosciences Inc. announced the acquisition of Adapt Pharma® for $635 million. Adapt markets NARCAN® Nasal Spray for the treatment of opioid overdose, for which Opia...
Source: ACCESSWIRE IA
Date: August, 30 2018 08:00
Sophiris Bio to Present at the H.C. Wainwright 20th Annual Global Investment Conference
SAN DIEGO and VANCOUVER, British Columbia , Aug. 29, 2018 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for th...
Source: PR Newswire
Date: August, 29 2018 16:30
Midday Gainers / Losers (08/29/2018)
Gainers: OPNT +50% . IGC +40% . GKOS +36% . EVFM +26% . IPAS +27% . SPHS +27% . AFMD +25% . JMU +19% . YRD +17% . ZYNE +17% . More news on: Opiant Pharmaceuticals, Inc., India Globalization Capital, Inc, Glaukos, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: August, 29 2018 12:48
Premarket Gainers as of 9:05 am (08/29/2018)
OPNT +79%  on EBS takeout of Adapt Pharma. More news on: Opiant Pharmaceuticals, Inc., Glaukos, India Globalization Capital, Inc, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: August, 29 2018 09:24

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-142.122.0692.15962.05155,377
2018-12-132.172.132.192.08137,188
2018-12-122.092.162.192.06197,030
2018-12-112.022.0992.122.01103,176
2018-12-102.042.022.041.95129,102

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1415,59852,21629.8721Cover
2018-12-1334,99439,91687.6691Short
2018-12-1247,78073,99764.5702Short
2018-12-1111,06232,04334.5224Cover
2018-12-1021,04838,48454.6929Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SPHS.


About Sophiris Bio, Inc. (NASDAQ: SPHS)

Logo for Sophiris Bio, Inc. (NASDAQ: SPHS)

Not available

 

 

 

Current Management

  • Lars Ekman / President
  • Alexander Casdin / CFO
  • Lars Ekman / Executive Chairman

Current Share Structure

     


    Recent Filings from (NASDAQ: SPHS)

    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: August, 30 2018
    Quarterly report with a continuing view of a company's financial position
    Filing Type: 10-QFiling Source: edgar
    Filing Date: August, 14 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: August, 14 2018
    Filing Type: CT ORDERFiling Source: edgar
    Filing Date: August, 03 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: June, 28 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: June, 25 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: May, 14 2018
    Quarterly report with a continuing view of a company's financial position
    Filing Type: 10-QFiling Source: edgar
    Filing Date: May, 14 2018
    Official notification to shareholders of matters to be brought to a vote (Proxy)
    Filing Type: DEF 14AFiling Source: edgar
    Filing Date: April, 27 2018
    Additional proxy soliciting materials - definitive
    Filing Type: DEFA14AFiling Source: edgar
    Filing Date: April, 27 2018

     

     


    Daily Technical Chart for (NASDAQ: SPHS)

    Daily Technical Chart for (NASDAQ: SPHS)


    Stay tuned for daily updates and more on (NASDAQ: SPHS)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: SPHS)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SPHS is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of SPHS and does not buy, sell, or trade any shares of SPHS. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/